Brain Cancer Research Institute is located in San Diego, CA. The organization was established in 2018. According to its NTEE Classification (G30) the organization is classified as: Cancer, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2022, Brain Cancer Research Institute employed 4 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Brain Cancer Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Brain Cancer Research Institute generated $92.8k in total revenue. The organization has seen a slow decline revenue. Over the past 4 years, revenues have fallen by an average of (0.1%) each year. All expenses for the organization totaled $681.1k during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE ORGANIZATION CONDUCTS RESEARCH AND TRIALS FOR DELIVERY OF PERSONALIZEDMEDICINE THROUGH A REGENERATIVE PROCESS AND THE UTILIZATION OF ARTIFICIALINTELLIGENCE. THIS RESEARCH IS CONDUCTED THROUGH THE USE OF TRANSDISCIPLINARYAPPROACHES FOR PRE-SYMPTOMATIC DETECTION AND PERSONALIZED THERAPEUTICS FOR VARIOUSCANCER AND AUTOIMMUNE DISORDER TREATMENTS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH AND TRIALS FOR DELIVERY OF PERSONALIZED MEDICINE THROUGH A REGENERATIVE PROCESS AND THE UTILIZATION OF ARTIFICIAL INTELLIGENCE. THIS RESEARCH IS CONDUCTED THROUGH THE USE OF TRANSDISCIPLINARY APPROACHES FOR PRE-SYMPTOMATIC DETECTION AND PERSONALIZED THERAPEUTICS FOR VARIOUS CANCER AND AUTOIMMUNE DISORDER TREATMENTS.
BRAIN CANCER RESEARCH: RESEARCH AND TRIALS SPECIFIC TO BRAIN CANCER FOR DELIVERY OF PERSONALIZED MEDICINE THROUGH A REGENERATIVE PROCESS AND THE UTILIZATION OF ARTIFICIAL INTELLIGENCE. THIS RESEARCH IS CONDUCTED THROUGH THE USE OF TRANSDISCIPLINARY APPROACHES FOR PRE-SYMPTOMATIC DETECTION AND PERSONALIZED THERAPEUTICS FOR BRAIN CANCER.
DEMENTIA RESEARCH:RESEARCH AND TRIALS SPECIFIC TO DEMENTIA FOR DELIVERY OF PERSONALIZED MEDICINE THROUGH A REGENERATIVE PROCESS AND THE UTILIZATION OF ARTIFICIAL INTELLIGENCE. THIS RESEARCH IS CONDUCTED THROUGH THE USE OF TRANSDISCIPLINARY APPROACHES FOR PRE-SYMPTOMATIC DETECTION AND PERSONALIZED THERAPEUTICS FOR DEMENTIA.
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Shashaanka Ashili CEO | OfficerTrustee | 1 | $89,730 |
Marlon Saria Director | Trustee | 1 | $0 |
Ben Williams Director | Trustee | 1 | $0 |
Bob Hotto Director | Trustee | 1 | $0 |
Jyothsna Kesari Chairman | Trustee | 1 | $0 |
Craig Lambert Director | Trustee | 1 | $0 |
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $14,181 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $14,181 |
| Total Program Service Revenue | $78,450 |
| Investment income | $174 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $92,805 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $89,730 |
| Compensation of current officers, directors, key employees. | $44,865 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $122,459 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $10,277 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $3,212 |
| Fees for services: Accounting | $19,029 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $9,806 |
| Office expenses | $13,917 |
| Information technology | $14,492 |
| Royalties | $0 |
| Occupancy | $62,716 |
| Travel | $2,850 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $52,531 |
| Insurance | $1,470 |
| All other expenses | $5,791 |
| Total functional expenses | $681,079 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $55,035 |
| Savings and temporary cash investments | $275,347 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $8,077 |
| Net Land, buildings, and equipment | $201,276 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $163,673 |
| Total assets | $703,408 |
| Accounts payable and accrued expenses | $15,650 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $15,650 |
| Net assets without donor restrictions | $232,868 |
| Net assets with donor restrictions | $454,890 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $703,408 |